Saving the World with Patents: Is the TRIPS Waiver helping or hurting innovation? June 15, 2021 - IPWatchdog.com
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Saving the World with Patents:
Is the TRIPS Waiver helping or hurting innovation?
June 15, 2021
Patent Analytics in LexisNexis® PatentSight®: Quality assessment
Technology Relevance™
Competitive Impact™
Worldwide citations received
from later patents, adjusted
(Individual patent strength)
for age, patent office practices
and technology field The relative business value
of a patent family
Patent Asset Index™
Average value: 1
X ∑
Market Coverage™
Market size protected by Innovative strength of a
active patents and pending company or portfolio
patent applications on a (ability to achieve
certain invention competitive advantage)!
Value of granted US patent: 1
Individual Patent
Family
2
Today’s speakers
Brian Arthur Melissa Brand Dr Sarbani Gene Quinn
Pomper Biotechnology Chattopadhyay IPWatchdog
Akin Gump Innovation Organization LexisNexis
(BIO) PatentSight
3
Vaccine
• A substance used to stimulate the production of antibodies and
provide immunity against one or several diseases, prepared from the
causative agent of a disease, its products, or a synthetic substitute,
treated to act as an antigen without inducing the disease
• Prophylactic vaccines are for prevention of disease
https://medlineplus.gov/ency/article/002024.htm
4
Overview of the Field
5
Filing Statistics of patents related to vaccines against viruses
A zoonosis is an infectious disease that has
jumped from a non-human animal to humans.
Zoonotic pathogens may be bacterial, viral or Swine
parasitic, or may involve unconventional flu
Ebola
agents and can spread to humans through
Bird flu MERS
direct contact or through food, water or the
environment. (WHO) Covid-19
SARS
6
https://www.who.int/news-room/fact-sheets/detail/zoonoses#:~:text=A%20zoonosis%20is%20an%20infectious,food%2C%20water%20or%20the%20environment
Top 20 companies, as per PatentSight®, in the field of antivirals related to
Corona virus family and related virus families (broad overview)
7
Coronaviridae family
Subunit vaccine Vector based vaccine
(optional: with adjuvants)
Conjugate vaccine Nucleic acid vaccine
Source: WHO: https://www.who.int/health-topics/coronavirus#tab=tab_1
Inactivated vaccine
8
Johnson & Johnson
9
Johnson & Johnson
10Johnson & Johnson
11Johnson & Johnson
12Novavax
13Novavax
14Novavax
https://www.novavax.com/our-unique-technology
15News
16
https://www.prnewswire.com/news-releases/novavax-to-present-at-international-society-for-vaccines-virtual-congress-covid-19-vaccine-update-301298080.html
https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3Sanofi
17Sanofi
18GlaxoSmithKline
19GlaxoSmithKline
20GlaxoSmithKline
21NEWS
22mRNA Based Vaccines
23mRNA Based Vaccines
24Thank you. www.patentsight.com Shelli Sombrio Senior Business Development Manager MSombrio@lexisnexisip.com +1 760-619-9689
Appendix
26Other Entities with Know How
27Focused Search for Patents Regarding Coronaviridae Spike Protein
Keywords specific to Spike proteins searched in
Title and/or Abstract in combination with related
IPC/CPC classes
28Zoetis
The vaccine is still experimental and hasn‘t yet been approved for use in animals in the US.
29
https://www.livescience.com/great-apes-covid-19-vaccine.htmlYou can also read
